ArticleNutrients2021

Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer's Disease.

Susanna C Larsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.